
We aimed to assess the potency and efficacy of zzso a zzso zzso zzso in the prevention of zzso and zzso observed in the pediatric patient population taking various chemotherapy zzso 

zzso zzso was given to 100 children (62 boys and 38 girls aged 6 months to 15 zzso with various zzso Patients received zzso during one or more courses of zzso chemotherapy for a total of 350 courses administered zzso or zzso and zzso zzso zzso zzso zzso 5 zzso was administered as a single intravenous dose slowly, before the start of chemotherapy on day 1 and zzso or by mouth on subsequent days zzso treatment zzso 5 zzso 

The patients receiving zzso chemotherapy had a zzso complete response rate and a zzso partial response rate during the first 24 h period of the first zzso We observed headache (five zzso zzso (three courses) and loss of appetite (one course) as zzso zzso 

zzso is safe, effective, easy to use, has no serious zzso and can be recommended for pediatric zzso The efficacy of zzso may be enhanced by the addition of zzso in patients receiving highly zzso cancer zzso 

